-308 Nco I polymorphism of tumour necrosis factor α in overweight Caucasians

Diabetes Research and Clinical Practice

Volumn 62, Issue 3, 2003, Pages 197-201

  Morris, Alison M ^a,c   Heilbronn, Leonie K ^a   Noakes, Manny ^b   Kind, Karen L ^b   Clifton, Peter M ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Obesity; Tumour necrosis factor alpha polymorphism; Weight loss

Indexed keywords

ADENINE; FATTY ACID; GLUCOSE; GUANINE; INSULIN; LIPID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUSTRALIA; BODY MASS; BODY REGIONS; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; DIET RESTRICTION; ENERGY; FATTY ACID BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; WEIGHT REDUCTION;

EID: 0242392010     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.08.002     Document Type: Article

References (17)

1. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95:(5):1995;2409-2415.
2. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA. 94:(7):1997;3195-3199.
3. Hamann A., Mantzoros C., Vidal-Puig A., Flier J.S. Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem. Biophys. Res. Commun. 211:(3):1995;833-839.
4. Fernandez-Real J.M., Gutierrez C., Ricart W., et al. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes. 46:(9):1997;1468-1472.
5. Herrmann S.M., Ricard S., Nicaud V., et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur. J. Clin. Invest. 28:(1):1998;59-66.
6. Hoffstedt J., Eriksson P., Hellstrom L., et al. Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia. 43:(1):2000;117-120.
7. Day C.P., Grove J., Daly A.K., et al. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia. 41:(4):1998;430-434.
8. Brand E., Schorr U., Kunz I., Kertmen E., Ringel J., Distler A., Sharma A. Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int. J. Obes. Relat. Metab. Disord. 25:(4):2001;581-585.
9. Dalziel B., Gosby A.K., Richman R.M., Bryson J.M., Caterson I.D. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes. Res. 10:(5):2002;401-407.
10. Walston J., Seibert M., Yen C.J., Cheskin L.J., Andersen R. Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance. Diabetes. 48:(10):1999;2096-2098.
11. Rasmussen S.K., Urhammer S.A., Jensen J.N., Hansen T., Borch-Johnsen K., Pedersen O. The -238 and -308 G-A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J. Clin. Endocrinol. Metab. 85:(4):2000;1731-1734.
12. da Sliva B., Gapstur S.M., Achenbach Y.H., Schuh T.S., Kotlar T.J., Liu K., Lowe W.L. Lack of association between the -308 polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome. J. Invest. Med. 48:(4):2000;236-244.
13. Koch M., Rett K., Volk A., et al. The tumour necrosis factor alpha -238G→A and -308G→A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II diabetic patients. Diabetologia. 43:(2):2000;181-184.
14. Ishii T., Hirose H., Saito I., Nishikai K., Maruyama H., Saruta T. Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. Metabolism. 49:(12):2000;1616-1618.
15. Furuta M., Yano Y., Ito K., et al. Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 56:(2):2002;141-145.
16. Foster C.B., Lehrnbecher T., Mol F., et al. Host defense molecule polymorphisms influence the risk for immune- mediated complications in chronic granulomatous disease. J. Clin. Invest. 102:(12):1998;2146-2155.
17. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science. 271:(5249):1996;665-668.